Researchers have discovered that Cell and Gene Therapy (CGT) has the potential to effectively target the root causes of chronic, rare diseases. It holds particular promise for rare diseases, which affect a small percentage of the population and often lack viable treatment options due to their complex and diverse nature. In addition to rare diseases, CGT also holds promise for more common conditions such as cancer and type 1 diabetes. This could lead to better outcomes for patients and potentially reduce the long-term side effects associated with current treatment options. As the field of CGT continues to grow, it is likely that we will see even more breakthroughs and advancements in the treatment of chronic, rare diseases.

Source: Economic Times October 07, 2023 23:00 UTC